Whalen Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Whalen Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$569K	Sell	3,610 -7,439	-67%	-$1.17M	0.24%	100
2026 Q2	$1.75M	Buy	11,049 +9,460	+595%	+$1.28M	0.79%	36
2026 Q1	$203K	Buy	+1,589	New	+$198K	0.11%	173
2025 Q1	–	Sell	-2,346	Closed	-$211K	–	180
2024 Q4	$211K	Buy	2,346 +61	+3%	+$5.91K	0.15%	135
2024 Q3	$226K	Sell	2,285 -18,778	-89%	-$1.84M	0.16%	105
2024 Q2	$1.95M	Buy	21,063 +5,336	+34%	+$478K	1.55%	17
2024 Q1	$1.49M	Buy	15,727 +1,854	+13%	+$172K	1.11%	16
2023 Q4	$1.24M	Buy	+13,873	New	+$1.03M	1.12%	13

Other funds holding XBI

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

BCG

Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

BONH

Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return

VAG

VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

WAM

Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

Whalen Wealth Management's XBI Position: Q3 2026 in Review

Whalen Wealth Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 67% in Q3 2026, selling an estimated $1.17M and leaving 3,610 shares worth $569K. The position accounts for 0.24% of the portfolio, ranked #100.

Whalen Wealth Management first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.95M in Q2 2024. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Whalen Wealth Management held 3,610 shares of State Street SPDR S&P Biotech ETF worth $569K as of Q3 2026.
Whalen Wealth Management sold 7,439 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.17M.
State Street SPDR S&P Biotech ETF made up 0.24% of Whalen Wealth Management's portfolio in Q3 2026, its #100 holding.
Whalen Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
Whalen Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $1.95M in Q2 2024.
39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Whalen Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.